Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR35 | Q9HC97 | 4/20 | 0.62 |
| ▸ | DAO | P14920 | 8/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.43 |
| ▸ | PLK4 | O00444 | 1/20 | 0.41 |
| ▸ | AURKA | O14965 | 1/20 | 0.41 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.41 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.41 |
| ▸ | CDK1 | P06493 | 1/20 | 0.41 |
| ▸ | PIM1 | P11309 | 1/20 | 0.41 |
| ▸ | PRKACA | P17612 | 1/20 | 0.41 |
| ▸ | CDK2 | P24941 | 1/20 | 0.41 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.41 |
| ▸ | CSNK1D | P48730 | 1/20 | 0.41 |
| ▸ | GSK3A | P49840 | 1/20 | 0.41 |
| ▸ | GSK3B | P49841 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21092213 | 0.81 | GPR35 (0.54) | GPR35DAOALDH1A1KDM4EMEN1 | |
| SCHEMBL16769661 | 0.80 | GPR35 (0.43) | GPR35DAOALDH1A1KDM4EMEN1 | |
| SCHEMBL26967303 | 0.78 | GPR35 (0.50) | GPR35DAOALDH1A1KDM4EMEN1 | |
| SCHEMBL12668159 | 0.78 | DAO (0.53) | GPR35DAOALDH1A1KDM4EMEN1 | |
| SCHEMBL1659859 | 0.78 | GPR35 (0.50) | GPR35DAOALDH1A1KDM4EMEN1 | |
| SCHEMBL9405053 | 0.78 | GPR35 (0.50) | GPR35DAOALDH1A1KDM4EMEN1 | |
| SCHEMBL12606667 | 0.77 | GPR35 (1.00) | GPR35DAOALDH1A1KDM4EMEN1 | |
| SCHEMBL18270783 | 0.77 | GPR35 (0.48) | GPR35DAOALDH1A1KDM4EMEN1 | |
| SCHEMBL18264118 | 0.77 | DAO (0.52) | GPR35DAOALDH1A1KDM4EMEN1 | |
| SCHEMBL18264048 | 0.77 | GPR35 (0.48) | GPR35DAOALDH1A1KDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024074141-A1 | POROUS MATERIAL AND APPLICATION THEREOF | 华为技术有限公司 | 2024-04-11 | — | — | WO | claimed |
| CN-119565569-A | Porous material and application thereof | 华为技术有限公司 | 2025-03-07 | — | — | CN | disclosed |
| WO-2024074141-A1 | POROUS MATERIAL AND APPLICATION THEREOF | 华为技术有限公司 | 2024-04-11 | — | — | WO | disclosed |
| US-20220023829-A1 | AMORPHOUS METAL ORGANIC FRAMEWORKS AND METHODS OF PREPARING THE SAME | ABSORPTION SOLUTIONS LLC | 2022-01-27 | — | — | US | disclosed |
| WO-2020117833-A2 | AMORPHOUS METAL ORGANIC FRAMEWORKS AND METHODS OF PREPARING THE SAME | FRAMERGY INC. (US) | 2020-06-11 | — | — | WO | disclosed |
| EP-3514159-A1 | ALUMINIUM METAL ORGANIC FRAMEWORK MATERIAL | The Texas A&M University System (US) | 2019-07-24 | — | — | EP | disclosed |
| EP-3143033-B1 | CHROMIUM METAL ORGANIC FRAMEWORKS AND SYNTHESIS OF METAL ORGANIC FRAMEWORKS | TEXAS A & M UNIV SYS (US) | 2019-04-10 | — | — | EP | disclosed |
| US-9951095-B2 | Chromium metal organic frameworks and synthesis of metal organic frameworks | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2018-04-24 | — | — | US | disclosed |
| US-9724668-B2 | Iron metal organic framework materials | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2017-08-08 | — | — | US | disclosed |
| US-20170050995-A1 | Chromium Metal Organic Frameworks and Synthesis of Metal Organic Frameworks | THE TEXAS A&M UNIVERSITY SYSTEM | 2017-02-23 | — | — | US | disclosed |
| US-20160346759-A1 | Iron Metal Organic Framework Materials | U.S. DEPARTMENT OF ENERGY | 2016-12-01 | — | — | US | disclosed |
| EP-2876112-B1 | Monocrystalline iron metal organic frameworks | TEXAS A & M UNIV SYS (US) | 2016-07-13 | — | — | EP | disclosed |
| WO-2015177511-A1 | METHOD OF PREPARING A METAL ORGANIC FRAMEWORK | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2015-11-26 | — | — | WO | disclosed |
| WO-2015173553-A1 | Chromium Metal Organic Frameworks and Synthesis of Metal Organic Frameworks | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2015-11-19 | — | — | WO | disclosed |
| US-9102691-B2 | Aluminum metal organic framework materials | TEXAS A&M UNIVERSITY SYSTEM (US) | 2015-08-11 | — | — | US | disclosed |
| US-20150152123-A1 | Aluminum Metal Organic Framework Materials | U.S. DEPARTMENT OF ENERGY | 2015-06-04 | — | — | US | disclosed |
| WO-2015079229-A1 | PROCESS FOR PREPARING METAL ORGANIC FRAMEWORK MATERIALS | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2015-06-04 | — | — | WO | disclosed |
| WO-2015079230-A1 | ALUMINIUM METAL ORGANIC FRAMEWORK MATERIALS | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2015-06-04 | — | — | WO | disclosed |
| EP-2876112-A1 | Monocrystalline iron metal organic frameworks | THE TEXAS A & M UNIVERSITY SYSTEM (US) | 2015-05-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170050995-A1 | Chromium Metal Organic Frameworks and Synthesis of Metal Organic Frameworks | OXGR1, TFRC, PICALM | GPR35 1912/4885DAO 1245/4885ALDH1A1 2898/4885 |
| US-20160346759-A1 | Iron Metal Organic Framework Materials | TFRC, FTH1, FECH | GPR35 4539/4885DAO 2609/4885ALDH1A1 3550/4885 |
| US-20150152123-A1 | Aluminum Metal Organic Framework Materials | AS3MT, ORAI2, ORAI3 | GPR35 3951/4885DAO 2070/4885ALDH1A1 1596/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.